Clinical trial
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00450320 · AIDS Malignancy Consortium, Other · Completed
Key facts
| NCT number | NCT00450320 |
|---|---|
| Title | Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma |
| Official title | A Pilot Study of Rapamycin in Patients With HIV-Related Kaposi's Sarcoma |
| Lead sponsor | AIDS Malignancy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH The Emmes Company, LLC Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug |
| Interventions | sirolimus |
| Enrollment | 7 |
| Start date | Oct 1, 2007 |
| Primary completion | Sep 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Mar 22, 2007 |
| Last update posted | Aug 29, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: